2:05
- gma3
- October 1, 2021
Possible COVID-19 treatment breakthrough
Merck said its Phase 3 trial indicates its new pill cuts the risk of “hospitalization or death” by 50% and may also be effective against new variants.
2:05
loading
Merck said its Phase 3 trial indicates its new pill cuts the risk of “hospitalization or death” by 50% and may also be effective against new variants.